Management of patients with inflammatory bowel disease (IBD) involves medical treatment, preventive care, and management of intestinal and extraintestinal symptoms. As a key part of team-based management of patients with IBD, primary care clinicians are responsible for much of the day-to-day care of these patients. This eCourse takes a case-based approach to exploring management of patients with IBD across a lifetime, including recommended preventive care, quality measures, cancer screening, and the benefits and risks of current treatment options.
Audio-enhanced slide lecture
To improve primary care management of patients with IBD by increasing knowledge of disease features and treatment, evidence-based quality measures, and recommended preventive care.
After completing this activity, participants will be better able to:
- Identify the risks and benefits of current treatment options for IBD to more effectively manage patients as part of a collaborative team
- Integrate strategies for preventing and treating extraintestinal manifestations of IBD as well as IBD-related complications
- Implement quality care measures for patients with IBD using evidence-based guidelines
Nurse practitioners and physician assistants
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing contact hours: 1.00, which includes 0.50 hours of pharmacology credit
CNE course advisor: Mary Knudtson, DNSc, NP, University of California, Santa Cruz
This program has been reviewed and is approved for a maximum of 1.00 AAPA Category 1 CME credits by the AAPA Review Panel. Approval is valid for one year from the issue date of April 17, 2017. Participants may submit the post-test at any time during that period.
This program was planned in accordance with AAPA CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
This activity is supported by an educational grant from AbbVie Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, the AAPA, or AbbVie.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are expected to disclose to the audience any significant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Ananthakrishnan: consulting: Takeda; scientific advisory board: AbbVie, Exact Sciences, Merck, Takeda.
Ms Kissous-Hunt: speaker fees: AbbVie, Janssen.
The Planning Committee for this activity included Ruth Cohen and Leslie Burgess of Continuing Education Alliance; Mary Knudtson, DNSc, NP, of the University of California, Santa Cruz; and Mark Christiansen, PhD, PA-C, of the University of the Pacific. The members of the Planning Committee have no significant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Listen to the presentation and study the program slides
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: April 17, 2017
Expiration date: April 17, 2018
© 2018 Practicing Clinicians Exchange. All Rights Reserved. APCE91616